Clinical trials
Diabetes Mellitus, Type 1 trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
48 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 3 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 6 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 28 |
| Unknown status | 6 |
| Recruiting | 5 |
| Terminated | 4 |
| Active, not recruiting | 3 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 8 |
| Sanofi | 7 |
| University of Sao Paulo | 6 |
| Mannkind Corporation | 5 |
| Novo Nordisk A/S | 5 |
| Hospital de Clinicas de Porto Alegre | 3 |
| Universidade Federal do Rio de Janeiro | 3 |
| Federal University of Rio Grande do Sul | 2 |
| Eurofarma Laboratorios S.A. | 1 |
| Federal University of São Paulo | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 1 | 48 |
| Diabetes Mellitus | 14 |
| Diabetes Mellitus, Type 2 | 8 |
| Periodontal Diseases | 3 |
| Autoimmune Diseases | 2 |
| Obesity | 2 |
| Overweight | 2 |
| Asthma | 1 |
| COVID-19 | 1 |
| Diabetic Cardiomyopathies | 1 |
Trials
Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.